SEC Tracker
Get the app
BTMD · XBRL financial data

biote financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (BTMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers45,55745,703*46,80449,16951,38449,834*48,99248,86347,95646,408*44,93544,232
Selling, general and administrative23,79126,190*23,01027,64924,02832,763*26,69224,22326,15124,744*27,78732,426
Operating income (loss)7,5995,508*10,4276,23312,1842,767*9,69010,7658,2676,829*3,166(3,508)
Other income (expense)(3)(2)*(2)(2)0*15*(18)(6)(3)(2)*(5)(6)
Income tax expense (benefit)3,874(2,744)*2,4861803,198(4,703)*1,6162,150(765)2,986*662296
Net income (loss)7,5307,734*(2,070)(6,322)10,7023,703*13,7183,1858,1881,954*2,277(6,563)
Earnings per share, basic USD per share0.25—(0.06)(0.19)0.34—0.440.100.260.06*0.07(0.23)
Earnings per share, diluted USD per share0.24—(0.06)(0.19)0.33—0.370.100.220.05*0.06(0.23)
Weighted average shares, basic thousands of shares30,334—34,62133,07231,04538,336*31,48631,62531,33230,698*30,64628,626
Weighted average shares, diluted thousands of shares31,041—34,62133,07232,26137,120*36,95331,74336,70941,215*35,99528,626

Balance sheet

CSV

Fiscal quarters (BTMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents65,57589,00278,78726,41938,22539,34241,70019,60128,04824,1235,32011,168
Short-term investments20,000———————————
Accounts receivable10,1776,8098,0227,7008,4937,6317,7659,0757,9726,8687,3977,810
Inventory11,07817,30718,91719,21216,20014,84513,45112,13216,44619,06419,88118,331
Prepaid and other current assets10,9239,2258,6358,4367,0656,3095,7648,6964,6574,6153,7585,731
Total current assets117,753122,343114,36161,76769,98368,12768,68049,50457,12354,67036,35643,040
Property and equipment, net1,3531,2182,1914,5235,8136,9738,3899,92810,06310,75310,70112,847
Right-of-use asset1,9531,8772,2022,1023,3763,2463,1132,9782,8412,7012,5586,846
Goodwill——5,5255,5165,5165,8335,8335,8335,8335,8335,8335,833
Total assets149,749155,295160,10892,900101,252122,370123,379104,798111,324107,61389,032101,699
Accounts payable5,6944,1554,1965,7934,3745,8133,3353,8634,3596,8268,2366,576
Accrued liabilities10,2798,4979,7296,8998,18511,29310,2288,98311,0789,80610,28214,321
Current portion of long-term debt6,2506,2506,2506,2506,2506,2506,2506,2506,2506,2506,2503,125
Total current liabilities25,08322,21524,05746,26646,51051,51448,47050,53756,30844,99128,22630,100
Long-term debt107,990106,630105,270103,909102,548101,19999,84798,48697,13095,78294,425118,377
Lease liability, non-current1,7611,6801,9171,8073,0262,8902,7472,6012,4522,2982,1376,433
Total liabilities201,014191,841205,008234,551228,076224,570208,205183,638176,791158,010136,987159,891
Accumulated deficit(40,522)(29,391)(31,303)(137,723)(124,717)(100,297)(84,346)(79,478)(63,760)(49,549)(46,032)(50,941)
Total stockholders' equity(40,529)(29,397)(35,399)(143,341)(130,342)(105,928)(89,981)(85,104)(72,751)(58,539)(56,091)(65,790)
Total liabilities and equity149,749155,295160,10892,900101,252122,370123,379104,798111,324107,61389,032101,699

Cash flows

CSV

Fiscal quarters (BTMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)7,5307,734*(2,070)(6,322)10,7023,703*13,7183,1858,1881,954*2,277(6,563)
Stock-based compensation2,243*1,997*1,7632,841*2,245*1,886*2,1272,186*2,410*2,198*1,7581,970*
Depreciation and amortization416*1,510*750876*810*1,138*857910*952*951*980963*
Net cash from operating activities160*6,956*7,3729,947*15,556*12,368*6,4677,086*14,072*7,569*3,902(1,176)*
Purchases of property and equipment451*(159)*7042,506*1,550*1,670*1,6301,809*499*1,077*3622,557*
Net cash from investing activities(484)*18,996*(12,176)(3,337)*(1,974)*(1,311)*(1,848)(1,962)*(690)*(2,364)*(1,168)(2,624)*
Share repurchases——4,0881,511*0*0*———0*1,0714,792*
Dividends paid1,000*1,106*834,120*453*88*694887*8*138*405616*
Net cash from financing activities(2,562)*(2,525)*(5,409)(58,972)*(1,768)*(9,934)*(2,257)(27,232)*(4,935)*(9,131)*(21,539)9,646*
Net change in cash(2,905)*23,427*(10,215)(52,368)*11,806*1,117*2,358(22,099)*8,447*(3,925)*(18,803)5,848*

Compare with peers

SIC 2833 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2833 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
biote11,16844,232(1,176)*not reported9.5 quarters 10-QJun 30, 2026
Assembly Biosciences32,286not reported(15,488)*20.4M20.7 quarters 10-QJun 30, 2026
Milestone Pharmaceuticals169,728559(22,714)*124.5M7.5 quarters 10-QJun 30, 2026
DiaMedica Therapeutics5,129not reported(8,114)*53.9M5.4 quarters 10-QJun 30, 2026
Carisma Therapeutics2,77745,3001,908*41.8M— 10-QSep 30, 2025
Larimar Therapeutics92,687not reported(44,030)*103.9M3.5 quarters 10-QJun 30, 2026
Ironwood Pharmaceuticals79,127113,04158,276*165.2M— 10-QJun 30, 2026
Vaxart50,92927,1852,778*242.8M— 10-QJun 30, 2026
Achieve Life Sciences47,958not reported(10,777)*102.9M17.4 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.